A carregar...

Long-Term Pharmacological Management of Phenylketonuria, Including Patients Below the Age of 4 Years

BH4 therapy is an advancement in the treatment of phenylketonuria, reducing blood phenylalanine (phe) levels and increasing tolerance to natural proteins of responding patients. We report the results of 16 patients undergoing long-term BH4 treatment. Responding patients to BH4 was usually based on 2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Couce, M L, Bóveda, M D, Valerio, E, Pérez-Muñuzuri, A, Fraga, J M
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3509844/
https://ncbi.nlm.nih.gov/pubmed/23430859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2011_53
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!